A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
暂无分享,去创建一个
Robbie Loewith | William A. Weiss | Kevan M. Shokat | Eli R. Zunder | David Stokoe | E. Zunder | K. Shokat | Z. Knight | B. González | M. Feldman | Roger L. Williams | R. Loewith | D. Stokoe | T. Balla | W. Weiss | B. Tóth | Tamas Balla | Zachary A. Knight | Beatriz Gonzalez | Morri E. Feldman | David D. Goldenberg | Olusegun Williams | Andras Balla | Balazs Toth | A. Balla | O. Williams
[1] E. Birney,et al. Pfam: the protein families database , 2013, Nucleic Acids Res..
[2] R. Nussbaum,et al. Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase , 2002, Mammalian Genome.
[3] William A Weiss,et al. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. , 2006, Cancer cell.
[4] K. Okkenhaug,et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils. , 2005, Blood.
[5] J. Engelman,et al. The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex , 2005, The Journal of cell biology.
[6] Kevan M Shokat,et al. Features of selective kinase inhibitors. , 2005, Chemistry & biology.
[7] S. Jackson,et al. Suppression of HIV-1 infection by a small molecule inhibitor of the ATM kinase , 2005, Nature Cell Biology.
[8] A. Robertson,et al. PI 3-kinase p110β: a new target for antithrombotic therapy , 2005, Nature Medicine.
[9] Kevan M Shokat,et al. Targeting the gatekeeper residue in phosphoinositide 3-kinases. , 2005, Bioorganic & medicinal chemistry.
[10] A. Bilancio,et al. Signalling by PI3K isoforms: insights from gene-targeted mice. , 2005, Trends in biochemical sciences.
[11] J. Engelman,et al. Phosphoinositide 3-Kinase Catalytic Subunit Deletion and Regulatory Subunit Deletion Have Opposite Effects on Insulin Sensitivity in Mice , 2005, Molecular and Cellular Biology.
[12] M. Lavin,et al. Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM. , 2005, Cancer research.
[13] L. Álvarez-Vallina,et al. Full Activation of PKB/Akt in Response to Insulin or Ionizing Radiation Is Mediated through ATM* , 2005, Journal of Biological Chemistry.
[14] L. S. Harrington,et al. Restraining PI3K: mTOR signalling goes back to the membrane. , 2005, Trends in biochemical sciences.
[15] A. Robertson,et al. PI 3-kinase p110beta: a new target for antithrombotic therapy. , 2005, Nature medicine.
[16] N. Curtin,et al. Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.
[17] B. Hemmings,et al. Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase*♦ , 2004, Journal of Biological Chemistry.
[18] Peter J. Alaimo,et al. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold. , 2004, Bioorganic & medicinal chemistry.
[19] L. Silengo,et al. PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects , 2004, Cell.
[20] N. Argade,et al. Regioselective quinazolinone-directed ortho lithiation of quinazolinoylquinoline: practical synthesis of naturally occurring human DNA topoisomerase I poison luotonin a and luotonins B and E. , 2004, The Journal of organic chemistry.
[21] Richard D. Byrne,et al. Bisperoxovanadium compounds are potent PTEN inhibitors , 2004, FEBS letters.
[22] J. Ptak,et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.
[23] J. Klein,et al. Positive and Negative Roles of p85α and p85β Regulatory Subunits of Phosphoinositide 3-Kinase in Insulin Signaling* , 2003, Journal of Biological Chemistry.
[24] ヴィスニック,メリーン,et al. Benzoxazin-3-ones and derivatives thereof as inhibitors of Pi3k , 2003 .
[25] ウアバーンス,クラウス,et al. Fused azole pyrimidine derivatives , 2003 .
[26] D. Staunton,et al. Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement , 2003, The Journal of Immunology.
[27] P. Finan,et al. Therapeutic potential of phosphoinositide 3-kinase inhibitors. , 2003, Chemistry & biology.
[28] 캐서린 레블랑,et al. 5-phenylthiazole derivatives and use as ??3 kinase inhibitors , 2003 .
[29] D. Staunton,et al. Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement. , 2003, Journal of immunology.
[30] J. Lakshmanan,et al. Analysis of insulin-stimulated glucose uptake in differentiated 3T3-L1 adipocytes. , 2003, Methods in molecular medicine.
[31] J. Klein,et al. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. , 2003, The Journal of biological chemistry.
[32] N. Tonks,et al. A Function for Phosphoinositide 3-Kinase β Lipid Products in Coupling βγ to Ras Activation in Response to Lysophosphatidic Acid* , 2002, The Journal of Biological Chemistry.
[33] N. Tonks,et al. A function for phosphoinositide 3-kinase beta lipid products in coupling beta gamma to Ras activation in response to lysophosphatidic acid. , 2002, The Journal of biological chemistry.
[34] Kohjiro Ueki,et al. Increased insulin sensitivity in mice lacking p85β subunit of phosphoinositide 3-kinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] 딕켄,et al. Inhibitors of human phosphatidyl-inositol 3-kinase delta , 2001 .
[36] John F. Timms,et al. Cellular function of phosphoinositide 3-kinases: Implications for development, immunity, homeostasis, and cancer , 2001 .
[37] K. Okkenhaug,et al. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. , 2001, Annual review of cell and developmental biology.
[38] Roger L. Williams,et al. Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. , 2000, Molecular cell.
[39] P. Seeburg,et al. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. , 2000, Science.
[40] Y. Yazaki,et al. p110β Is Up-regulated during Differentiation of 3T3-L1 Cells and Contributes to the Highly Insulin-responsive Glucose Transport Activity* , 2000, The Journal of Biological Chemistry.
[41] Christian Ried,et al. Structural insights into phosphoinositide 3-kinase catalysis and signalling , 1999, Nature.
[42] J. Kuriyan,et al. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. , 1999, Molecular cell.
[43] R. Nussbaum,et al. Proliferative Defect and Embryonic Lethality in Mice Homozygous for a Deletion in the p110α Subunit of Phosphoinositide 3-Kinase* , 1999, The Journal of Biological Chemistry.
[44] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Backer,et al. Regulation of the p85/p110 Phosphatidylinositol 3′-Kinase: Stabilization and Inhibition of the p110α Catalytic Subunit by the p85 Regulatory Subunit , 1998, Molecular and Cellular Biology.
[46] L. Cantley,et al. Phosphoinositide kinases. , 1998, Annual review of biochemistry.
[47] M. Waterfield,et al. Using structure to define the function of phosphoinositide 3‐kinase family members , 1997, FEBS letters.
[48] Joel Morris,et al. A Cyclodehydration Route to 2-Aminochromones , 1994 .
[49] Susan S. Taylor,et al. cAMP‐dependent protein kinase: Crystallographic insights into substrate recognition and phosphotransfer , 1994, Protein science : a publication of the Protein Society.
[50] L. Cantley,et al. Identification and quantification of polyphosphoinositides produced in response to platelet-derived growth factor stimulation. , 1991, Methods in enzymology.
[51] L. Cantley,et al. Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[52] M. Iradyan,et al. Imidazole derivatives , 1977 .
[53] V. Armstrong,et al. A new brominating reagent: 2-Carboxyethyltriphenylphosphonium perbromide , 1975 .
[54] J. Lombardino. Preparation and New Reactions of Imidazo[1,2-a]pyridines , 1965 .